{"filter":{"health_condition":"type2_diabetes"},"n_projects":85,"projects":[{"accession":"PRJEB11419","age_categories":{"adolescent":93,"adult":4213,"child":99,"elderly":790,"infant":79,"neonate":1,"unknown":2078},"countries":{"AE":2,"AT":3,"AU":25,"BE":9,"BR":3,"CA":45,"CH":3,"CN":2,"CR":1,"CZ":1,"DE":15,"ES":481,"FM":1,"FR":10,"GB":864,"GE":1,"HK":2,"HR":2,"IE":6,"IT":5,"JE":1,"JP":528,"LV":2,"MD":1,"MN":2,"MX":547,"MY":1,"NL":4,"NO":5,"NZ":1,"PH":86,"PR":1,"RS":3,"SE":1,"TH":6,"US":3501,"ZA":2},"first_public_year":"2015","gbp_per_sample_median":0.12,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":419,"cardiometabolic_other":110,"crohns_disease":7,"gi_infection_or_diarrhoea":26,"healthy_control":241,"ibd_unspecified":46,"ibs":560,"kidney_disease":41,"liver_disease":40,"neurological_psychiatric":379,"other_cancer":218,"other_disease":925,"pregnancy_postpartum":1,"type2_diabetes":91,"ulcerative_colitis":14},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":7353,"papers":[{"doi":"10.1016/j.csbj.2020.08.028","pmcid":"PMC7516180","pmid":"33005310","title":"Multi-population cohort meta-analysis of human intestinal microbiota in early life reveals the existence of infant community state types (ICSTs)."},{"doi":"10.3389/fmolb.2022.949563","pmcid":"PMC9403272","pmid":"36032669","title":"Genomic reconstruction of short-chain fatty acid production by the human gut microbiota."},{"doi":"10.12938/bmfh.2023-043","pmcid":"PMC10767325","pmid":"38188664","title":"Heterogeneity of gut microbiome compositions in the third decade of life in Japanese women: insights from a comparative analysis."},{"doi":"10.1128/msystems.00929-24","pmcid":"PMC11494892","pmid":"39287373","title":"Exploring the vitamin biosynthesis landscape of the human gut microbiota."},{"doi":"10.1128/msystems.00031-18","pmcid":"PMC5954204","pmid":"29795809","title":"American Gut: an Open Platform for Citizen Science Microbiome Research."}],"sample_intervention_arms":{},"sex":{"female":3603,"male":2157},"title":"American Gut Project","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB11419","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB11419_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB11419.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB11419.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB11419.csv.gz"}},{"accession":"PRJEB32762","age_categories":{"adult":3419,"elderly":342,"infant":1,"neonate":3},"countries":{"AR":1126,"ES":119,"GB":732,"US":1764},"first_public_year":"2019","gbp_per_sample_median":0.18,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"allergy_or_atopy":180,"healthy_control":1157,"neurological_psychiatric":1779,"other_disease":4,"type2_diabetes":16},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":3765,"papers":[{"doi":"10.1177/1352458520924594","pmcid":"PMC7968892","pmid":"33115343","title":"Household paired design reduces variance and increases power in multi-city gut microbiome study in multiple sclerosis."},{"doi":"10.1016/j.cell.2022.08.021","pmcid":"PMC10143502","pmid":"36113426","title":"Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course."},{"doi":"10.1128/spectrum.02183-24","pmcid":"PMC11974365","pmid":"39998261","title":"Reevaluation of the gastrointestinal methanogenic archaeome in multiple sclerosis and its association with treatment."},{"doi":"10.1038/s41564-025-02225-y","pmcid":"PMC13244660","pmid":"41507585","title":"Gut microbial ethanol metabolism contributes to auto-brewery syndrome in an observational cohort."},{"doi":"10.1128/msystems.00416-26","pmcid":"PMC13483414","pmid":"42484622","title":"Integrative multicohort analysis reveals consistent sex differences in gut microbiota of multiple sclerosis patients."}],"sample_intervention_arms":{},"sex":{"female":1820,"male":1647},"title":"iMSMS Baranzini data","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB32762","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB32762_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB32762.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB32762.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB32762.csv.gz"}},{"accession":"PRJEB100670","age_categories":{"adult":1826},"countries":{"SE":1826},"first_public_year":"2025","gbp_per_sample_median":6.7,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":1826},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":1826,"papers":[{"doi":"10.1038/s41591-025-04009-7","pmcid":"PMC12823436","pmid":"41482560","title":"Multi-omic definition of metabolic obesity through adipose tissue-microbiome interactions."}],"sample_intervention_arms":{},"sex":{},"title":"The gut microbiota in pre-diabetes and type-2 diabetes","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB100670","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB100670_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB100670.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB100670.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB100670.csv.gz"}},{"accession":"PRJNA643353","age_categories":{"adult":1156,"elderly":36},"countries":{"CN":1192},"first_public_year":"2021","gbp_per_sample_median":10.73,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":1192},"intervention_design":"randomized_controlled_trial","intervention_detail":"Berberine and/or probiotics vs placebo, with gentamycin run-in pretreatment","interventions":["antibiotic","drug_therapy","probiotic"],"n_samples":1192,"papers":[{"doi":"10.1038/s41467-020-18414-8","pmcid":"PMC7538905","pmid":"33024120","title":"Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)."},{"doi":"10.1080/19490976.2021.2003176","pmcid":"PMC8726654","pmid":"34923903","title":"Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study."},{"doi":"10.1038/s41564-021-00920-0","pmcid":"PMC8318886","pmid":"34226711","title":"Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner."},{"doi":"10.1002/imt2.179","pmcid":"PMC11170963","pmid":"38882498","title":"Deciphering unique and shared interactions between the human gut microbiota and oral antidiabetic drugs."},{"doi":"10.1016/j.heliyon.2024.e37986","pmcid":"PMC11438002","pmid":"39347390","title":"Clinical significance of the genetically variable landscape of the gut microbiome in patients with gestational diabetes mellitus patients."}],"sample_intervention_arms":{"antibiotic":403,"drug_therapy":85,"no_intervention":405,"other_intervention":104,"placebo":97,"probiotic":98},"sex":{"female":146,"male":216},"title":"The gut microbiome related effect of Berberine and probiotics in treating Type 2 Diabetes","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA643353","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA643353_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA643353.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA643353.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA643353.csv.gz"}},{"accession":"PRJEB38742","age_categories":{"adult":260,"elderly":185,"unknown":573},"countries":{"DE":269,"DK":294,"FR":455},"first_public_year":"2020","gbp_per_sample_median":2.95,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":603,"healthy_control":1,"obesity":157,"type2_diabetes":213},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":1018,"papers":[{"doi":"10.1038/s41467-020-19589-w","pmcid":"PMC7676231","pmid":"33208748","title":"Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology."},{"doi":"10.1136/gutjnl-2021-325753","pmcid":"PMC9664128","pmid":"35017197","title":"Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism."},{"doi":"10.1038/s41591-022-01688-4","pmcid":"PMC8863577","pmid":"35177860","title":"Microbiome and metabolome features of the cardiometabolic disease spectrum."},{"doi":"10.1038/s41467-023-39824-4","pmcid":"PMC10511707","pmid":"37730687","title":"Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide."},{"doi":"10.1038/s41591-024-03067-7","pmcid":"PMC11620793","pmid":"38918632","title":"Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes."}],"sample_intervention_arms":{},"sex":{"female":99,"male":368},"title":"Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB38742","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB38742_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB38742.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB38742.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB38742.csv.gz"}},{"accession":"PRJEB64515","age_categories":{"adolescent":6,"adult":351,"child":1,"elderly":292,"unknown":296},"countries":{"PL":946},"first_public_year":"2023","gbp_per_sample_median":0.09,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":6,"other_cancer":64,"other_disease":206,"other_infection":574,"type1_diabetes":1,"type2_diabetes":95},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":946,"papers":[{"doi":"10.3389/fmicb.2024.1342749","pmcid":"PMC11219902","pmid":"38962119","title":"Gut microbiome dynamics and predictive value in hospitalized COVID-19 patients: a comparative analysis of shallow and deep shotgun sequencing."},{"doi":"10.1093/gigascience/giaf015","pmcid":"PMC11927397","pmid":"40117176","title":"Healthy microbiome-moving towards functional interpretation."}],"sample_intervention_arms":{},"sex":{"female":238,"male":412},"title":"Gut Microbiome Dynamics and Predictive Value in Hospitalized COVID-19 Patients: A Comparative Analysis of Shallow and Deep Shotgun Sequencing","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB64515","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB64515_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB64515.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB64515.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB64515.csv.gz"}},{"accession":"PRJEB37249","age_categories":{"unknown":888},"countries":{"DE":292,"DK":241,"FR":355},"first_public_year":"2020","gbp_per_sample_median":2.99,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":295,"healthy_control":232,"type2_diabetes":52},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":888,"papers":[{"doi":"10.1038/s41467-020-19589-w","pmcid":"PMC7676231","pmid":"33208748","title":"Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology."},{"doi":"10.1136/gutjnl-2021-325753","pmcid":"PMC9664128","pmid":"35017197","title":"Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism."},{"doi":"10.1038/s41591-022-01688-4","pmcid":"PMC8863577","pmid":"35177860","title":"Microbiome and metabolome features of the cardiometabolic disease spectrum."},{"doi":"10.1038/s41598-022-14055-7","pmcid":"PMC9209496","pmid":"35725732","title":"Deep embeddings to comprehend and visualize microbiome protein space."},{"doi":"10.1186/s12864-022-09087-2","pmcid":"PMC9789565","pmid":"36564713","title":"Machine learning framework for gut microbiome biomarkers discovery and modulation analysis in large-scale obese population."}],"sample_intervention_arms":{},"sex":{"female":428,"male":176},"title":"Statin therapy is associated with lower prevalence of gut microbiota dysbiosis","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB37249","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB37249_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB37249.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB37249.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB37249.csv.gz"}},{"accession":"PRJEB64861","age_categories":{"adult":706},"countries":{"IL":706},"first_public_year":"2023","gbp_per_sample_median":0.91,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":706},"intervention_design":"randomized_controlled_trial","intervention_detail":"Six-month personalized postprandial glucose-targeting diet vs Mediterranean diet in pre-diabetics","interventions":["diet_intervention"],"n_samples":706,"papers":[{"doi":"10.1530/erp-15-0028","pmcid":"PMC5323868","pmid":"27249813","title":"An extracardiac unruptured right sinus of valsalva aneurysm complicated with atherothrombosis."},{"doi":"10.1038/s41467-023-41042-x","pmcid":"PMC10477304","pmid":"37666816","title":"Impact of dietary interventions on pre-diabetic oral and gut microbiome, metabolites and cytokines."},{"doi":"10.1186/s40168-026-02405-w","pmcid":"PMC13181886","pmid":"41952172","title":"Cross-body site microbial interactions influence the human plasma metabolome."}],"sample_intervention_arms":{"diet_intervention":702},"sex":{},"title":"Impact of dietary interventions on pre-diabetic oral and gut microbiome, metabolites and cytokines","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB64861","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB64861_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB64861.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB64861.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB64861.csv.gz"}},{"accession":"PRJNA1201249","age_categories":{"adult":662},"countries":{"SG":662},"first_public_year":"2024","gbp_per_sample_median":7.93,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Calorie-restricted, legume-enriched diet vs calorie-restricted control diet","interventions":["diet_intervention"],"n_samples":662,"papers":[{"doi":"10.1038/s41467-025-56084-6","pmcid":"PMC11754483","pmid":"39843443","title":"A legume-enriched diet improves metabolic health in prediabetes mediated through gut microbiome: a randomized controlled trial."},{"doi":"10.1186/s40168-026-02405-w","pmcid":"PMC13181886","pmid":"41952172","title":"Cross-body site microbial interactions influence the human plasma metabolome."}],"sample_intervention_arms":{},"sex":{},"title":"Legume-enriched diet improves metabolic health in prediabetes partially mediated through gut microbiome: a randomized controlled trial","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1201249","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1201249_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1201249.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1201249.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1201249.csv.gz"}},{"accession":"PRJNA1505569","age_categories":{"adult":438},"countries":{"US":438},"first_public_year":"2026","gbp_per_sample_median":1.96,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":438},"intervention_design":"crossover","intervention_detail":"DASH-style diet vs typical US diet, 5-week feeding periods","interventions":["diet_intervention"],"n_samples":438,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"A DASH diet increases microbiome diversity, butyrate production, and circulating acetate in persons with type 2 diabetes: Results from the DASH4D randomized feeding trial","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1505569","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1505569_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1505569.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1505569.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1505569.csv.gz"}},{"accession":"PRJEB56830","age_categories":{"unknown":430},"countries":{"FR":173,"NL":257},"first_public_year":"2024","gbp_per_sample_median":6.19,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":430},"intervention_design":"randomized_controlled_trial","intervention_detail":"High-protein vs low-protein isocaloric diet, 12 weeks","interventions":["diet_intervention"],"n_samples":430,"papers":[{"doi":"10.1016/j.isci.2023.107471","pmcid":"PMC10432813","pmid":"37599833","title":"Protein supplementation changes gut microbial diversity and derived metabolites in subjects with type 2 diabetes."}],"sample_intervention_arms":{"diet_intervention":288,"no_intervention":142},"sex":{},"title":"Isocaloric dietary protein intervention","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB56830","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB56830_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB56830.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB56830.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB56830.csv.gz"}},{"accession":"PRJNA1062586","age_categories":{"adult":421},"countries":{"CN":421},"first_public_year":"2024","gbp_per_sample_median":4.5,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type1_diabetes":421},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":421,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Raw sequence reads of fecal metagenomics in diabetes mellitus population","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1062586","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1062586_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1062586.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1062586.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1062586.csv.gz"}},{"accession":"PRJEB91718","age_categories":{"adult":365,"elderly":18},"countries":{"PL":383},"first_public_year":"2025","gbp_per_sample_median":10.05,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":1,"healthy_control":141,"other_cancer":24,"other_disease":73,"other_infection":97,"type2_diabetes":47},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":383,"papers":[{"doi":"10.3389/fmicb.2024.1342749","pmcid":"PMC11219902","pmid":"38962119","title":"Gut microbiome dynamics and predictive value in hospitalized COVID-19 patients: a comparative analysis of shallow and deep shotgun sequencing."}],"sample_intervention_arms":{},"sex":{"female":95,"male":147},"title":"COVID-19 Microbiome - deep samples","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB91718","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB91718_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB91718.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB91718.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB91718.csv.gz"}},{"accession":"PRJNA422434","age_categories":{"adolescent":2,"adult":328,"elderly":40},"countries":{"CN":370},"first_public_year":"2012","gbp_per_sample_median":3.35,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":183,"type2_diabetes":183},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":370,"papers":[{"doi":"10.1038/nature11450","pmcid":null,"pmid":"23023125","title":"A metagenome-wide association study of gut microbiota in type 2 diabetes."},{"doi":"10.1073/pnas.2023202118","pmcid":"PMC8201803","pmid":"34083435","title":"A catalog of tens of thousands of viruses from human metagenomes reveals hidden associations with chronic diseases."},{"doi":"10.3389/fimmu.2017.01430","pmcid":"PMC5671494","pmid":"29163505","title":"IL17eScan: A Tool for the Identification of Peptides Inducing IL-17 Response."},{"doi":"10.1186/s12864-020-07357-5","pmcid":"PMC7814594","pmid":"33468056","title":"Prediction and analysis of metagenomic operons via MetaRon: a pipeline for prediction of Metagenome and whole-genome opeRons."},{"doi":"10.1101/gr.276306.121","pmcid":"PMC9248880","pmid":"35545448","title":"Rapid evolution and strain turnover in the infant gut microbiome."}],"sample_intervention_arms":{},"sex":{"female":145,"male":194},"title":"A metagenome-wide association study of gut microbiota in type 2 diabetes.","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA422434","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA422434_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA422434.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA422434.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA422434.csv.gz"}},{"accession":"PRJNA613947","age_categories":{"adult":78,"elderly":254,"unknown":16},"countries":{"CN":348},"first_public_year":"2020","gbp_per_sample_median":6.33,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":95,"healthy_control":221,"type2_diabetes":11},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":348,"papers":[{"doi":"10.1038/s41586-022-05620-1","pmcid":"PMC9892008","pmid":"36653448","title":"The person-to-person transmission landscape of the gut and oral microbiomes."},{"doi":"10.1371/journal.pcbi.1013883","pmcid":"PMC12810900","pmid":"41525322","title":"Integrative analysis across metagenomic taxonomic classifiers: A case study of the gut microbiome in aging and longevity in the Integrative Longevity Omics Study."},{"doi":"10.3390/microorganisms11102560","pmcid":"PMC10609127","pmid":"37894218","title":"A Pipeline for Constructing Reference Genomes for Large Cohort-Specific Metagenome Compression."},{"doi":"10.1080/19490976.2024.2393756","pmcid":"PMC11364081","pmid":"39197040","title":"Consistent signatures in the human gut microbiome of longevous populations."},{"doi":"10.1080/19490976.2024.2426623","pmcid":"PMC11559365","pmid":"39529240","title":"Biosynthetic potential of the gut microbiome in longevous populations."}],"sample_intervention_arms":{},"sex":{"female":178,"male":169},"title":"human gut metagenome Metagenome","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA613947","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA613947_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA613947.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA613947.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA613947.csv.gz"}},{"accession":"PRJNA734860","age_categories":{"adult":269,"elderly":72},"countries":{"US":341},"first_public_year":"2023","gbp_per_sample_median":2.83,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":125},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":341,"papers":[{"doi":"10.1002/hep.32197","pmcid":"PMC8930512","pmid":"34633706","title":"Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease."},{"doi":"10.1128/msystems.00033-22","pmcid":"PMC9238400","pmid":"35477306","title":"Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas."},{"doi":"10.1128/msystems.00434-24","pmcid":"PMC11406975","pmid":"39166873","title":"Gut phageome in Mexican Americans: a population at high risk for metabolic dysfunction-associated steatotic liver disease and diabetes."},{"doi":"10.1080/19490976.2024.2399260","pmcid":"PMC11382720","pmid":"39239875","title":"Protection against fibrosis by a bacterial consortium in metabolic dysfunction-associated steatohepatitis and the role of amino acid metabolism."},{"doi":"10.1002/hep4.1490","pmcid":"PMC7109342","pmid":"32258950","title":"Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican-American Population of South Texas"}],"sample_intervention_arms":{},"sex":{"female":238,"male":103},"title":"Stool microbiome of Hispanics in the Cameron County Hispanic Cohort","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA734860","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA734860_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA734860.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA734860.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA734860.csv.gz"}},{"accession":"PRJEB61646","age_categories":{"unknown":332},"countries":{"FI":332},"first_public_year":"2023","gbp_per_sample_median":10.41,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":332,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Microbiome interactions in development of T2D (MB-MeT2D)","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB61646","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB61646_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB61646.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB61646.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB61646.csv.gz"}},{"accession":"PRJDB11444","age_categories":{"adult":290},"countries":{"JP":290},"first_public_year":"2023","gbp_per_sample_median":8.46,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":97,"healthy_control":101,"obesity":92},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":290,"papers":[{"doi":"10.1038/s41586-023-06466-x","pmcid":"PMC10499599","pmid":"37648852","title":"Gut microbial carbohydrate metabolism contributes to insulin resistance."},{"doi":"10.1038/s41598-026-56821-x","pmcid":"PMC13526866","pmid":"42289444","title":"Fatigue-associated gut bacteria in Japanese healthy adults characterized by metagenomic analysis."},{"doi":"10.1101/2025.06.16.659887","pmcid":null,"pmid":null,"title":"Biome-specific genome catalogues reveal functional potential of shallow sequencing"}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome of prediabetes in Japan","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB11444","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB11444_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB11444.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB11444.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB11444.csv.gz"}},{"accession":"PRJEB5224","age_categories":{"unknown":260},"countries":{"CN":11,"DK":109,"ES":140},"first_public_year":"2014","gbp_per_sample_median":5.64,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":10,"type1_diabetes":31,"type2_diabetes":79},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":260,"papers":[{"doi":"10.1038/nbt.2942","pmcid":null,"pmid":"24997786","title":"An integrated catalog of reference genes in the human gut microbiome."},{"doi":"10.1038/s41467-025-59019-3","pmcid":"PMC12041579","pmid":"40301344","title":"Global diversity and distribution of antibiotic resistance genes in human wastewater treatment systems."},{"doi":"10.1038/nature15766","pmcid":"PMC4681099","pmid":"26633628","title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota."},{"doi":"10.15252/msb.20177589","pmcid":"PMC5740502","pmid":"29242367","title":"Subspecies in the global human gut microbiome."},{"doi":"10.1016/j.cell.2019.08.003","pmcid":"PMC6736778","pmid":"31474368","title":"Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy."}],"sample_intervention_arms":{},"sex":{"female":122,"male":115},"title":"An integrated catalog of reference genes in the human gut microbiome","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB5224","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB5224_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB5224.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB5224.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB5224.csv.gz"}},{"accession":"PRJEB38625","age_categories":{"adult":157,"elderly":87},"countries":{"ES":244},"first_public_year":"2022","gbp_per_sample_median":1.84,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"allergy_or_atopy":1,"healthy_control":33,"obesity":8,"other_cancer":25,"other_disease":8,"type2_diabetes":2},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":244,"papers":[{"doi":"10.1136/gutjnl-2021-324755","pmcid":"PMC9185815","pmid":"35260444","title":"A faecal microbiota signature with high specificity for pancreatic cancer."},{"doi":"10.1016/j.isci.2024.109294","pmcid":"PMC10915599","pmid":"38450156","title":"Highly accurate diagnosis of pancreatic cancer by integrative modeling using gut microbiome and exposome data."},{"doi":"10.1097/js9.0000000000001762","pmcid":"PMC11487005","pmid":"38874485","title":"The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing."},{"doi":"10.1016/j.cpblue.2026.100034","pmcid":"PMC13269251","pmid":"42312244","title":"Strain transmission links human microbiomes along the oral-gut axis and across cohabiting individuals."}],"sample_intervention_arms":{},"sex":{"female":49,"male":87},"title":"The oral and fecal microbiome in chronic pancreatitis and pancreatic cancer.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB38625","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB38625_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB38625.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB38625.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB38625.csv.gz"}},{"accession":"PRJEB62817","age_categories":{"adult":226},"countries":{"LV":226},"first_public_year":"2023","gbp_per_sample_median":6.74,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":226},"intervention_design":"single_arm_before_after","intervention_detail":"Metformin monotherapy in newly diagnosed T2D, sampled before/after","interventions":["drug_therapy"],"n_samples":226,"papers":[{"doi":"10.1080/19490976.2024.2361491","pmcid":"PMC11178274","pmid":"38868903","title":"Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB62817","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB62817_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB62817.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB62817.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB62817.csv.gz"}},{"accession":"PRJEB15179","age_categories":{"adult":220},"countries":{"CN":220},"first_public_year":"2018","gbp_per_sample_median":15.01,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":220},"intervention_design":"randomized_controlled_trial","intervention_detail":"WTP diet vs usual care in T2D patients","interventions":["diet_intervention"],"n_samples":220,"papers":[{"doi":"10.1186/s40168-023-01604-z","pmcid":"PMC10408196","pmid":"37553697","title":"Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions."},{"doi":"10.1002/imt2.20","pmcid":"PMC10989819","pmid":"38868565","title":"A neural network-based framework to understand the type 2 diabetes-related alteration of the human gut microbiome."}],"sample_intervention_arms":{"diet_intervention":148,"no_intervention":72},"sex":{},"title":"Using WTP diet to modulate gut microbiota to alleviate human type 2 diabetes","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB15179","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB15179_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB15179.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB15179.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB15179.csv.gz"}},{"accession":"PRJEB53551","age_categories":{"adult":212},"countries":{},"first_public_year":"2024","gbp_per_sample_median":7.37,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":27,"type2_diabetes":185},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT vs placebo in diabetic peripheral neuropathy patients","interventions":["fmt"],"n_samples":212,"papers":[],"sample_intervention_arms":{"fmt":105,"placebo":45},"sex":{},"title":"FMT alleviates peripheral neuropathy in patients with diabetes mellitus","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB53551","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB53551_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB53551.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB53551.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB53551.csv.gz"}},{"accession":"PRJEB44907","age_categories":{"unknown":208},"countries":{"CN":208},"first_public_year":"2021","gbp_per_sample_median":2.99,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Berberine and/or Bifidobacterium vs placebo, 16-week RCT","interventions":["drug_therapy","probiotic"],"n_samples":208,"papers":[{"doi":"10.1186/s13073-021-00942-7","pmcid":"PMC8351344","pmid":"34365978","title":"Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study."}],"sample_intervention_arms":{},"sex":{},"title":"Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB44907","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB44907_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB44907.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB44907.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB44907.csv.gz"}},{"accession":"PRJEB39500","age_categories":{"adult":203},"countries":{"LV":203},"first_public_year":"2021","gbp_per_sample_median":0.95,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":103,"type2_diabetes":100},"intervention_design":"single_arm_before_after","intervention_detail":"Metformin 2x850mg/day; healthy and newly-diagnosed T2D patients sampled over time","interventions":["drug_therapy"],"n_samples":203,"papers":[{"doi":"10.1371/journal.pone.0241338","pmcid":"PMC7598494","pmid":"33125401","title":"Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients."},{"doi":"10.1128/mbio.00169-24","pmcid":"PMC11237675","pmid":"38767350","title":"Changes in the type 2 diabetes gut mycobiome associate with metformin treatment across populations."}],"sample_intervention_arms":{"drug_therapy":203},"sex":{},"title":"Baseline gut microbiome composition predicts metformin therapy short term efficacy in newly diagnosed type 2 diabetes patients","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB39500","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB39500_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB39500.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB39500.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB39500.csv.gz"}},{"accession":"PRJEB12124","age_categories":{"adult":186,"elderly":2},"countries":{"CN":188},"first_public_year":"2016","gbp_per_sample_median":5.7,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":188},"intervention_design":"randomized_controlled_trial","intervention_detail":"Acarbose vs Glipizide (sulfonylurea) oral antidiabetic drugs in treatment-naive T2D patients","interventions":["drug_therapy"],"n_samples":188,"papers":[{"doi":"10.1038/s41467-017-01682-2","pmcid":"PMC5702614","pmid":"29176714","title":"Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment."},{"doi":"10.1128/mbio.00095-20","pmcid":"PMC7157763","pmid":"32265336","title":"Synergy between Cell Surface Glycosidases and Glycan-Binding Proteins Dictates the Utilization of Specific Beta(1,3)-Glucans by Human Gut Bacteroides."},{"doi":"10.1128/mbio.03628-20","pmcid":"PMC8262883","pmid":"34061597","title":"Human Gut Faecalibacterium prausnitzii Deploys a Highly Efficient Conserved System To Cross-Feed on β-Mannan-Derived Oligosaccharides."},{"doi":"10.1016/j.chom.2022.02.001","pmcid":"PMC9096808","pmid":"35240043","title":"Diverse events have transferred genes for edible seaweed digestion from marine to human gut bacteria."},{"doi":"10.1038/s41467-024-47272-x","pmcid":"PMC11009399","pmid":"38605009","title":"Plasmids in the human gut reveal neutral dispersal and recombination that is overpowered by inflammatory diseases."}],"sample_intervention_arms":{"drug_therapy":94},"sex":{"female":72,"male":116},"title":"Gut microbiome-dependent stratification of patients for anti-diabetic treatment","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB12124","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB12124_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB12124.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB12124.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB12124.csv.gz"}},{"accession":"PRJNA686835","age_categories":{"adult":182},"countries":{"CN":182},"first_public_year":"2021","gbp_per_sample_median":4.72,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":52,"obesity":52,"type2_diabetes":78},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":182,"papers":[{"doi":"10.1002/advs.202100536","pmcid":"PMC8373164","pmid":"34085773","title":"Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes."},{"doi":"10.1126/scitranslmed.abk0855","pmcid":"PMC9746350","pmid":"35675435","title":"Risk assessment with gut microbiome and metabolite markers in NAFLD development."},{"doi":"10.1186/s40168-024-01990-y","pmcid":"PMC11730835","pmid":"39810263","title":"Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease."},{"doi":"10.1186/s12866-025-04348-y","pmcid":"PMC12522779","pmid":"41087898","title":"Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome."},{"doi":"10.1186/s12967-025-07443-w","pmcid":"PMC12763994","pmid":"41316248","title":"Characterization of the gut virome in patients with nonalcoholic fatty liver disease."}],"sample_intervention_arms":{},"sex":{},"title":"Human gut microbiota Raw sequence reads from medication-naive individuals who are lean or abdominally obese subjects with and without T2D","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA686835","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA686835_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA686835.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA686835.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA686835.csv.gz"}},{"accession":"PRJNA826552","age_categories":{"adult":173,"elderly":8},"countries":{"CN":181},"first_public_year":"2022","gbp_per_sample_median":9.26,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":181},"intervention_design":"randomized_controlled_trial","intervention_detail":"Acarbose vs vildagliptin, 24-week RCT in T2D patients","interventions":["drug_therapy"],"n_samples":181,"papers":[{"doi":"10.1007/s00125-022-05768-5","pmcid":"PMC9477956","pmid":"35930018","title":"Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised tr"},{"doi":"10.1002/imt2.179","pmcid":"PMC11170963","pmid":"38882498","title":"Deciphering unique and shared interactions between the human gut microbiota and oral antidiabetic drugs."}],"sample_intervention_arms":{"drug_therapy":82,"no_intervention":82},"sex":{"female":72,"male":92},"title":"human gut metagenome Raw sequence reads","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA826552","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA826552_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA826552.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA826552.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA826552.csv.gz"}},{"accession":"PRJEB14155","age_categories":{"adult":172},"countries":{"CN":172},"first_public_year":"2018","gbp_per_sample_median":14.77,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":172},"intervention_design":"none","intervention_detail":"Two dietary regimens used to modulate gut microbiota in T2D patients","interventions":[],"n_samples":172,"papers":[{"doi":"10.1038/s41467-023-40552-y","pmcid":"PMC10435514","pmid":"37591886","title":"Gut microbiota-derived tryptamine and phenethylamine impair insulin sensitivity in metabolic syndrome and irritable bowel syndrome."},{"doi":"10.1038/s41586-021-04091-0","pmcid":"PMC10258454","pmid":"34819672","title":"The human microbiome encodes resistance to the antidiabetic drug acarbose."},{"doi":"10.1002/imt2.20","pmcid":"PMC10989819","pmid":"38868565","title":"A neural network-based framework to understand the type 2 diabetes-related alteration of the human gut microbiome."},{"doi":"10.1002/imt2.179","pmcid":"PMC11170963","pmid":"38882498","title":"Deciphering unique and shared interactions between the human gut microbiota and oral antidiabetic drugs."}],"sample_intervention_arms":{},"sex":{},"title":"Using two diets to modulate gut microbiota to alleviate human type 2 diabetes","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB14155","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB14155_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB14155.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB14155.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB14155.csv.gz"}},{"accession":"PRJEB59861","age_categories":{"adult":154},"countries":{"NO":154},"first_public_year":"2026","gbp_per_sample_median":5.06,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":154},"intervention_design":"randomized_controlled_trial","intervention_detail":"Gastric bypass (RYGB) vs sleeve gastrectomy (SG) for T2D","interventions":["surgery"],"n_samples":154,"papers":[{"doi":"10.1136/bmjopen-2018-024573","pmcid":"PMC6561424","pmid":"31167860","title":"Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and ß-cel"},{"doi":"10.1016/s2213-8587(19)30344-4","pmcid":null,"pmid":"31678062","title":"Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial."},{"doi":"10.1038/s42255-026-01525-9","pmcid":"PMC13218940","pmid":"42098417","title":"Gut microbiota responses to bariatric surgery are associated with metabolic outcomes and type 2 diabetes remission."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiota alterations after gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg)","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB59861","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB59861_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB59861.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB59861.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB59861.csv.gz"}},{"accession":"PRJNA1053635","age_categories":{"adult":150},"countries":{"CN":150},"first_public_year":"2024","gbp_per_sample_median":8.39,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":150,"papers":[{"doi":"10.1038/s41467-024-51864-y","pmcid":"PMC11402979","pmid":"39278950","title":"An expanded database and analytical toolkit for identifying bacterial virulence factors and their associations with chronic diseases."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic sequencing of T2D patients","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1053635","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1053635_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1053635.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1053635.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1053635.csv.gz"}},{"accession":"PRJEB77105","age_categories":{"adult":148},"countries":{"SE":148},"first_public_year":"2024","gbp_per_sample_median":7.84,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":148},"intervention_design":"randomized_controlled_trial","intervention_detail":"Broccoli sprout extract (sulforaphane) once daily for 12 weeks vs placebo","interventions":["dietary_supplement"],"n_samples":148,"papers":[{"doi":"10.1038/s41564-025-01932-w","pmcid":"PMC11879859","pmid":"39929977","title":"Effect of broccoli sprout extract and baseline gut microbiota on fasting blood glucose in prediabetes: a randomized, placebo-controlled trial."}],"sample_intervention_arms":{},"sex":{"female":42,"male":88},"title":"Sulforaphane reduces fasting blood glucose in prediabetes","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB77105","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB77105_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB77105.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB77105.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB77105.csv.gz"}},{"accession":"PRJEB1786","age_categories":{"elderly":145},"countries":{"DE":4,"DK":2,"EE":1,"FI":1,"FR":1,"HU":1,"IS":1,"NO":1,"SE":130,"SK":3},"first_public_year":"2013","gbp_per_sample_median":2.81,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":43,"type2_diabetes":53},"intervention_design":"unknown","intervention_detail":"Observational case-control cohort, no administered intervention","interventions":[],"n_samples":145,"papers":[{"doi":"10.1073/pnas.2023202118","pmcid":"PMC8201803","pmid":"34083435","title":"A catalog of tens of thousands of viruses from human metagenomes reveals hidden associations with chronic diseases."},{"doi":"10.1186/s13059-015-0611-7","pmcid":"PMC4389708","pmid":"25853934","title":"Average genome size estimation improves comparative metagenomics and sheds light on the functional ecology of the human microbiome."},{"doi":"10.1371/journal.pone.0140827","pmcid":"PMC4610706","pmid":"26479726","title":"Type 2 Diabetes Biomarkers of Human Gut Microbiota Selected via Iterative Sure Independent Screening Method."},{"doi":"10.1186/s12859-020-3533-7","pmcid":"PMC7218625","pmid":"32397982","title":"TAMA: improved metagenomic sequence classification through meta-analysis."},{"doi":"10.1186/s40168-022-01237-8","pmcid":"PMC8908641","pmid":"35272700","title":"MetaDecoder: a novel method for clustering metagenomic contigs."}],"sample_intervention_arms":{},"sex":{"female":145},"title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB1786","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB1786_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB1786.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB1786.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB1786.csv.gz"}},{"accession":"PRJNA801067","age_categories":{"adult":134},"countries":{"CN":134},"first_public_year":"2026","gbp_per_sample_median":12.53,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":134},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":134,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Feces Raw sequence reads","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA801067","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA801067_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA801067.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA801067.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA801067.csv.gz"}},{"accession":"PRJNA891875","age_categories":{"adult":132},"countries":{"CN":132},"first_public_year":"2023","gbp_per_sample_median":10.11,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":42,"type2_diabetes":90},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":132,"papers":[{"doi":"10.1080/19490976.2023.2226925","pmcid":"PMC10291934","pmid":"37349979","title":"Alterations in the gut virome are associated with type 2 diabetes and diabetic nephropathy."},{"doi":"10.1038/s41467-025-58856-6","pmcid":"PMC11986028","pmid":"40210629","title":"Characterization of the phyllosphere virome of fresh vegetables and potential transfer to the human gut."}],"sample_intervention_arms":{},"sex":{},"title":"Human gut Metagenome","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA891875","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA891875_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA891875.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA891875.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA891875.csv.gz"}},{"accession":"PRJEB30611","age_categories":{"adult":126},"countries":{"CN":126},"first_public_year":"2021","gbp_per_sample_median":7.69,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":126,"papers":[{"doi":"10.3389/fcimb.2021.598672","pmcid":"PMC7930378","pmid":"33680988","title":"The Fecal Microbiota Is Already Altered in Normoglycemic Individuals Who Go on to Have Type 2 Diabetes."}],"sample_intervention_arms":{},"sex":{},"title":"The fecal microbiota has already altered in normoglycemic individuals who go on to have type 2 diabetes","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB30611","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB30611_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB30611.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB30611.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB30611.csv.gz"}},{"accession":"PRJNA1238858","age_categories":{"adult":120},"countries":{"CN":120},"first_public_year":"2025","gbp_per_sample_median":6.31,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":120},"intervention_design":"randomized_controlled_trial","intervention_detail":"USFA (MUFA/PUFA) feeding timed at lunch vs dinner, 12-week RCT","interventions":["diet_intervention"],"n_samples":120,"papers":[{"doi":"10.1038/s41467-025-58937-6","pmcid":"PMC12056104","pmid":"40328731","title":"Timing of unsaturated fat intake improves insulin sensitivity via the gut microbiota-bile acid axis: a randomized controlled trial."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic sequencing of fecal samples","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1238858","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1238858_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1238858.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1238858.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1238858.csv.gz"}},{"accession":"PRJEB21612","age_categories":{"adult":97,"elderly":20},"countries":{"CN":117},"first_public_year":"2022","gbp_per_sample_median":5.44,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":61,"healthy_control":37,"type2_diabetes":19},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":117,"papers":[{"doi":"10.3389/fcimb.2017.00381","pmcid":"PMC5573791","pmid":"28884091","title":"Alterations of the Gut Microbiome in Hypertension."},{"doi":"10.3389/fmicb.2023.1309709","pmcid":"PMC10753005","pmid":"38156010","title":"Antibiotic resistance profiles of gut microbiota across various primate species in Guangxi."},{"doi":"10.1186/s12866-025-04500-8","pmcid":"PMC13001194","pmid":"41654729","title":"A validation for sex differences in gut microbiome of essential hypertension based on cohort analysis."},{"doi":"10.4103/mgr.medgasres-d-25-00128","pmcid":"PMC13456470","pmid":"42493771","title":"Hypertension and gut microbial hydrogenases: a comparison of hydrogen metabolism and etiology."}],"sample_intervention_arms":{},"sex":{"female":51,"male":65},"title":"Alterations of the gut microbiome in hypertension","trial_population_condition":"cardiometabolic_other","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB21612","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB21612_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB21612.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB21612.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB21612.csv.gz"}},{"accession":"PRJNA454826","age_categories":{"adult":107},"countries":{"HK":107},"first_public_year":"2019","gbp_per_sample_median":5.62,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":107},"intervention_design":"single_arm_before_after","intervention_detail":"12-week high-intensity exercise training in prediabetic males","interventions":["exercise"],"n_samples":107,"papers":[{"doi":"10.1080/19490976.2024.2416928","pmcid":"PMC11533799","pmid":"39473051","title":"Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study."},{"doi":"10.1186/s40168-023-01604-z","pmcid":"PMC10408196","pmid":"37553697","title":"Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions."},{"doi":"10.1186/s40168-024-01990-y","pmcid":"PMC11730835","pmid":"39810263","title":"Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease."}],"sample_intervention_arms":{"exercise":70,"no_intervention":37},"sex":{"male":107},"title":"Human gut metagenome Raw sequence reads upon exercise intervention","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA454826","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA454826_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA454826.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA454826.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA454826.csv.gz"}},{"accession":"PRJNA1306676","age_categories":{"adult":100},"countries":{"US":100},"first_public_year":"2026","gbp_per_sample_median":3.97,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":2,"cardiometabolic_other":34,"healthy_control":38,"other_infection":11,"type2_diabetes":15},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":100,"papers":[{"doi":"10.1101/2025.08.25.25334409","pmcid":null,"pmid":null,"title":"Preeclampsia-Associated Microbiome Alterations Across Maternal Niches and Infant Gut"}],"sample_intervention_arms":{},"sex":{"female":55,"male":45},"title":"Multiple body sites microbiome in women with Preeclampsia and their infants","trial_population_condition":"pregnancy_postpartum","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1306676","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1306676_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1306676.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1306676.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1306676.csv.gz"}},{"accession":"PRJNA1096686","age_categories":{"adult":53,"elderly":43},"countries":{"US":96},"first_public_year":"2024","gbp_per_sample_median":0.64,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":6,"crohns_disease":16,"healthy_control":12,"ibd_unspecified":3,"neurological_psychiatric":36,"other_cancer":10,"other_disease":1,"type2_diabetes":3,"ulcerative_colitis":5},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":96,"papers":[{"doi":"10.1038/s41531-025-00894-4","pmcid":"PMC11923181","pmid":"40108151","title":"Comparative analysis of Parkinson's and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion."}],"sample_intervention_arms":{},"sex":{"female":47,"male":49},"title":"A comparative analysis of Parkinson's disease, inflammatory bowel disease, and control gut microbiomes with shotgun metagenomics","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1096686","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1096686_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1096686.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1096686.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1096686.csv.gz"}},{"accession":"PRJNA811727","age_categories":{"adult":96},"countries":{"CN":96},"first_public_year":"2023","gbp_per_sample_median":6.87,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":96},"intervention_design":"randomized_controlled_trial","intervention_detail":"Probio-X probiotic plus metformin vs placebo plus metformin, 3 months","interventions":["probiotic"],"n_samples":96,"papers":[{"doi":"10.1128/msystems.01300-22","pmcid":"PMC9948714","pmid":"36688679","title":"Adjunctive Probio-X Treatment Enhances the Therapeutic Effect of a Conventional Drug in Managing Type 2 Diabetes Mellitus by Promoting Short-Chain Fatty Acid-Producing Bacteria and Bile Acid Pathways."}],"sample_intervention_arms":{"placebo":64,"probiotic":32},"sex":{},"title":"Probio-X combined with metformin alleviates type 2 diabetes by mediating short-chain fatty acid-producing bacteria and bile acid pathways","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA811727","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA811727_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA811727.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA811727.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA811727.csv.gz"}},{"accession":"PRJEB52732","age_categories":{"adult":95},"countries":{},"first_public_year":"2024","gbp_per_sample_median":10.44,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":95},"intervention_design":"randomized_controlled_trial","intervention_detail":"","interventions":[],"n_samples":95,"papers":[],"sample_intervention_arms":{"diet_intervention":67,"no_intervention":28},"sex":{},"title":"Follow up of gut microbitoa targeted interventioon","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB52732","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB52732_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB52732.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB52732.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB52732.csv.gz"}},{"accession":"PRJNA624763","age_categories":{"adult":27,"elderly":68},"countries":{"CN":95},"first_public_year":"2020","gbp_per_sample_median":11.69,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":3,"cardiometabolic_other":2,"healthy_control":86,"liver_disease":1,"other_infection":2,"type2_diabetes":1},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":95,"papers":[{"doi":"10.1080/19490976.2024.2393756","pmcid":"PMC11364081","pmid":"39197040","title":"Consistent signatures in the human gut microbiome of longevous populations."},{"doi":"10.1371/journal.pone.0305583","pmcid":"PMC11488730","pmid":"39423213","title":"Comprehensive gut microbiota composition and microbial interactions among the three age groups."},{"doi":"10.3389/fnagi.2026.1745455","pmcid":"PMC13021664","pmid":"41907847","title":"Examination of shared gut microbiome signatures in aging and Parkinson's disease."},{"doi":"10.1038/s41467-026-71521-w","pmcid":"PMC13079874","pmid":"41980943","title":"Comprehensive benchmarking of metagenomic binning tools reveals key factors for improved genome recovery."}],"sample_intervention_arms":{},"sex":{"female":56,"male":39},"title":"Shotgun metagenomics of human gut microbiota in China high longevity area","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA624763","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA624763_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA624763.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA624763.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA624763.csv.gz"}},{"accession":"PRJNA728680","age_categories":{"adult":51,"elderly":44},"countries":{"US":95},"first_public_year":"2022","gbp_per_sample_median":4.07,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_infection":14,"transplant_or_immunocompromised":23,"type2_diabetes":52},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT vs delayed FMT for MDRO decolonization in transplant recipients","interventions":["fmt"],"n_samples":95,"papers":[{"doi":"10.1126/scitranslmed.abo2750","pmcid":"PMC10821315","pmid":"37910603","title":"Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":51,"no_intervention":44},"sex":{"female":52,"male":43},"title":"PREMIX","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA728680","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA728680_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA728680.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA728680.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA728680.csv.gz"}},{"accession":"PRJDB9649","age_categories":{"unknown":88},"countries":{"CN":88},"first_public_year":"2022","gbp_per_sample_median":9.13,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT from healthy donors via mid-gut vs placebo for diabetic peripheral neuropathy","interventions":["fmt"],"n_samples":88,"papers":[{"doi":"10.1016/j.cmet.2023.06.010","pmcid":null,"pmid":"37451270","title":"Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal microbiota transplantation alleviates diabetes peripheral neuropathy","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB9649","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB9649_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB9649.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB9649.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB9649.csv.gz"}},{"accession":"PRJNA588805","age_categories":{"adult":87},"countries":{"NZ":87},"first_public_year":"2020","gbp_per_sample_median":4.33,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":87},"intervention_design":"randomized_controlled_trial","intervention_detail":"Randomised RYGB vs sleeve gastrectomy bariatric surgery","interventions":["surgery"],"n_samples":87,"papers":[{"doi":"10.1007/s11695-020-04684-0","pmcid":null,"pmid":"32447634","title":"Gut Microbial Predictors of Type 2 Diabetes Remission Following Bariatric Surgery."}],"sample_intervention_arms":{"surgery":87},"sex":{},"title":"Gut microbiome changes after bariatric surgery","trial_population_condition":"obesity","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA588805","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA588805_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA588805.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA588805.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA588805.csv.gz"}},{"accession":"PRJEB60243","age_categories":{"adult":84},"countries":{"AE":84},"first_public_year":"2023","gbp_per_sample_median":0.16,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":44,"type2_diabetes":40},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":84,"papers":[{"doi":"10.1038/s41598-023-49679-w","pmcid":"PMC10725451","pmid":"38104165","title":"Functional alterations and predictive capacity of gut microbiome in type 2 diabetes."}],"sample_intervention_arms":{},"sex":{},"title":"Functional Alterations and Predictive Capacity of Gut Microbiome in Type 2 Diabetes","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB60243","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB60243_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB60243.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB60243.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB60243.csv.gz"}},{"accession":"PRJNA1475610","age_categories":{"adult":81,"elderly":1},"countries":{"CN":82},"first_public_year":"2026","gbp_per_sample_median":7.51,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":41,"type2_diabetes":41},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":82,"papers":[{"doi":"10.3389/fmicb.2026.1902019","pmcid":"PMC13522148","pmid":"42666298","title":"Multi-layer gut microbiome variation in type 2 diabetes despite preserved higher-order community structure."}],"sample_intervention_arms":{},"sex":{"female":35,"male":47},"title":"Shotgun metagenomic profiling of the gut microbiome in type 2 diabetes mellitus and healthy controls","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1475610","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1475610_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1475610.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1475610.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1475610.csv.gz"}},{"accession":"PRJNA1470177","age_categories":{"adult":74},"countries":{"IN":74},"first_public_year":"2026","gbp_per_sample_median":0.22,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":74},"intervention_design":"randomized_controlled_trial","intervention_detail":"Mustadi Ghana Vati, Varadi Ghana Vati (herbal formulations) or Metformin","interventions":["drug_therapy"],"n_samples":74,"papers":[],"sample_intervention_arms":{"drug_therapy":74},"sex":{},"title":"Changes in the Gut Microbiome Following Mustadi Ghana Vati, Varadi Ghana Vati and Metformin Interventions in Type 2 Diabetes: A 24-Week Baseline to Post-Treatment Analysis","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1470177","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1470177_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1470177.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1470177.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1470177.csv.gz"}},{"accession":"PRJNA806510","age_categories":{"adult":72},"countries":{"CN":72},"first_public_year":"2025","gbp_per_sample_median":10.58,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":72},"intervention_design":"observational_with_procedure","intervention_detail":"Metformin monotherapy in newly diagnosed T2DM patients","interventions":["drug_therapy"],"n_samples":72,"papers":[{"doi":"10.1016/j.apsb.2025.02.008","pmcid":"PMC12145038","pmid":"40487637","title":"A critical role for <i>Phocaeicola vulgatus</i> in negatively impacting metformin response in diabetes."}],"sample_intervention_arms":{"drug_therapy":22,"no_intervention":28},"sex":{"female":5,"male":5},"title":"Study of Gut Microbiota Mediated Metformin Monotherapy Failure in Type 2 Diabetes Mellitus","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA806510","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA806510_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA806510.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA806510.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA806510.csv.gz"}},{"accession":"PRJNA673918","age_categories":{"adult":71},"countries":{"CN":71},"first_public_year":"2021","gbp_per_sample_median":7.25,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":71},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation in T2DM patients","interventions":["fmt"],"n_samples":71,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Shorgun metagenomics of T2DM human gut microbes associated with FMT","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA673918","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA673918_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA673918.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA673918.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA673918.csv.gz"}},{"accession":"PRJNA1378533","age_categories":{"unknown":70},"countries":{"PL":70},"first_public_year":"2025","gbp_per_sample_median":0.16,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":70},"intervention_design":"randomized_controlled_trial","intervention_detail":"Multi-strain probiotic 12 weeks vs placebo, with metformin","interventions":["probiotic"],"n_samples":70,"papers":[{"doi":"10.64898/2026.02.06.26345743","pmcid":null,"pmid":null,"title":"Multi-strain probiotic enhances metformin tolerance by modulating gut microbiome and bile acid pathways: Insight from multi-omics post-hoc analysis (ProGasMet trial)"},{"doi":"10.3389/fendo.2026.1765741","pmcid":"PMC12991998","pmid":"41852479","title":"Multi-strain probiotic reduces gastrointestinal side effects in women with elevated HOMA-IR index treated with metformin: a 12-week randomised controlled trial."},{"doi":"10.1016/j.biopha.2026.119370","pmcid":null,"pmid":"41985330","title":"Multi-strain probiotic enhances metformin tolerance by modulating gut microbiome and bile acid pathways: Insight from multi-omics post-hoc analysis (ProGasMet trial)."}],"sample_intervention_arms":{"no_intervention":35},"sex":{},"title":"Multi-strain probiotic enhances metformin tolerance by modulating gut microbiome and bile acid pathways","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1378533","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1378533_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1378533.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1378533.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1378533.csv.gz"}},{"accession":"PRJNA1096331","age_categories":{"adult":64},"countries":{"NZ":64},"first_public_year":"2025","gbp_per_sample_median":2.23,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":64},"intervention_design":"randomized_controlled_trial","intervention_detail":"Higher-protein nut bar vs higher-carbohydrate cereal bar, 12-week parallel-group trial","interventions":["diet_intervention"],"n_samples":64,"papers":[{"doi":"10.3390/nu16121971","pmcid":"PMC11206330","pmid":"38931324","title":"Effect of a Higher-Protein Nut versus Higher-Carbohydrate Cereal Enriched Diet on the Gut Microbiomes of Chinese Participants with Overweight and Normoglycaemia or Prediabetes in the Tū Ora Study."}],"sample_intervention_arms":{},"sex":{"female":24,"male":40},"title":"Effect of Dietary High-Protein Nut versus High-Carbohydrate Cereal Supplementation on the Gut Microbiomes of Chinese Participants with Prediabetes","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1096331","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1096331_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1096331.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1096331.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1096331.csv.gz"}},{"accession":"PRJNA1192958","age_categories":{"adult":55,"elderly":5},"countries":{"IN":60},"first_public_year":"2026","gbp_per_sample_median":0.31,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":33,"type2_diabetes":27},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":60,"papers":[],"sample_intervention_arms":{},"sex":{"female":20,"male":40},"title":"Human gut microbiome of healthy and T2D cohorts of India","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1192958","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1192958_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1192958.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1192958.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1192958.csv.gz"}},{"accession":"PRJNA1258611","age_categories":{"elderly":60},"countries":{"CN":60},"first_public_year":"2025","gbp_per_sample_median":14.84,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":60},"intervention_design":"none","intervention_detail":"In vitro fecal fermentation comparing whole grain blend (black/red/brown rice) vs polished white rice","interventions":[],"n_samples":60,"papers":[{"doi":"10.3390/foods14152557","pmcid":"PMC12345654","pmid":"40807496","title":"Comparing a Whole Grain Blend with Polished White Rice for Starch Digestibility and Gut Microbiota Fermentation in Diabetic Patients: An In Vitro Study."}],"sample_intervention_arms":{"diet_intervention":40,"no_intervention":20},"sex":{},"title":"Comparing a Whole Grain Blend with Polished White Rice on Gut Microbiota Fermentation in Diabetic Patients","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1258611","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1258611_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1258611.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1258611.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1258611.csv.gz"}},{"accession":"PRJNA1356513","age_categories":{"adult":58,"elderly":2},"countries":{"PR":60},"first_public_year":"2025","gbp_per_sample_median":1.36,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ibd_unspecified":58,"type2_diabetes":2},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":60,"papers":[{"doi":"10.1093/ibd/izag161","pmcid":null,"pmid":"42647084","title":"Diet quality, gut microbiome, and inflammatory signatures in Puerto Rican adults with Crohn disease: a multidimensional analysis."}],"sample_intervention_arms":{},"sex":{"female":28,"male":32},"title":"Dieta Anti-INflamatoria (DAIN) study","trial_population_condition":"crohns_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1356513","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1356513_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1356513.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1356513.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1356513.csv.gz"}},{"accession":"PRJNA626062","age_categories":{"adult":54},"countries":{"CN":54},"first_public_year":"2020","gbp_per_sample_median":0.02,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":20,"type2_diabetes":34},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from healthy donors to 17 T2DM patients, 12-week follow-up","interventions":["fmt"],"n_samples":54,"papers":[{"doi":"10.3389/fcimb.2022.820367","pmcid":"PMC8990819","pmid":"35402293","title":"Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients."}],"sample_intervention_arms":{"fmt":34,"no_intervention":20},"sex":{},"title":"Fecal microbiota transplant therapy in type 2 diabetes patients.","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA626062","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA626062_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA626062.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA626062.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA626062.csv.gz"}},{"accession":"PRJNA1281554","age_categories":{"adolescent":48},"countries":{"US":48},"first_public_year":"2025","gbp_per_sample_median":1.4,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":48},"intervention_design":"randomized_controlled_trial","intervention_detail":"Randomized to metformin alone vs metformin+liraglutide for 3 months","interventions":["drug_therapy"],"n_samples":48,"papers":[{"doi":"10.1080/19490976.2025.2558071","pmcid":"PMC12482426","pmid":"41020378","title":"Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study."}],"sample_intervention_arms":{},"sex":{},"title":"Targeting the Gut Microbiome in Youth-Onset Type 2 Diabetes: Effects of Metformin and Liraglutide Therapy","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1281554","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1281554_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1281554.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1281554.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1281554.csv.gz"}},{"accession":"PRJNA588627","age_categories":{"unknown":46},"countries":{"CN":46},"first_public_year":"2019","gbp_per_sample_median":11.23,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":29,"type2_diabetes":17},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":46,"papers":[{"doi":"10.3389/fcimb.2020.575084","pmcid":"PMC7862107","pmid":"33552999","title":"Enteric Phageome Alterations in Patients With Type 2 Diabetes."}],"sample_intervention_arms":{},"sex":{},"title":"human gut metagenome Metagenome","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA588627","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA588627_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA588627.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA588627.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA588627.csv.gz"}},{"accession":"PRJNA486795","age_categories":{"adult":44},"countries":{"CN":44},"first_public_year":"2018","gbp_per_sample_median":8.97,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Metformin 3-day treatment in newly diagnosed T2D patients","interventions":["drug_therapy"],"n_samples":44,"papers":[{"doi":"10.1038/s41591-018-0222-4","pmcid":"PMC6479226","pmid":"30397356","title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin."},{"doi":"10.1371/journal.pone.0242021","pmcid":"PMC7707550","pmid":"33259474","title":"Perturbation of the human gastrointestinal tract microbial ecosystem by oral drugs to treat chronic disease results in a spectrum of individual specific patterns of extinction and persistence of domin"},{"doi":"10.1128/mbio.00169-24","pmcid":"PMC11237675","pmid":"38767350","title":"Changes in the type 2 diabetes gut mycobiome associate with metformin treatment across populations."}],"sample_intervention_arms":{"drug_therapy":22,"no_intervention":22},"sex":{},"title":"Modification of gut microbiota-bile acid-intestinal FXR signaling leads to the clinical benefits of metformin","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA486795","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA486795_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA486795.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA486795.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA486795.csv.gz"}},{"accession":"PRJNA1471479","age_categories":{"adult":43},"countries":{"CN":43},"first_public_year":"2026","gbp_per_sample_median":11.81,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":43},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":43,"papers":[{"doi":"10.3389/fimmu.2026.1893357","pmcid":"PMC13581658","pmid":"42755618","title":"Genome-resolved gut metagenomics identifies an <i>Escherichia coli</i>-<i>Collinsella</i> signature associated with Wagner 4 gangrenous diabetic foot ulcers."}],"sample_intervention_arms":{},"sex":{},"title":"Genome-resolved gut metagenomics identifies an Escherichia coli-Collinsella signature associated with Wagner grade 4 diabetic foot ulcers","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1471479","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1471479_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1471479.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1471479.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1471479.csv.gz"}},{"accession":"PRJNA1475489","age_categories":{"adult":17,"elderly":22},"countries":{"US":39},"first_public_year":"2026","gbp_per_sample_median":0.16,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"allergy_or_atopy":2,"autoimmune_inflammatory":2,"colorectal_cancer":2,"healthy_control":19,"neurological_psychiatric":12,"type2_diabetes":2},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":39,"papers":[{"doi":"10.1080/29933935.2026.2679810","pmcid":"PMC13251516","pmid":"42282268","title":"Brain health and the gut microbiome (bMicrobiome Study): a proof-of-concept, feasibility study integrating shotgun metagenomics, metrology, and multidimensional phenotyping across the cognitive aging "}],"sample_intervention_arms":{},"sex":{"female":35,"male":4},"title":"Brain Health and the Gut Microbiome (bMicrobiome Study)","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1475489","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1475489_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1475489.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1475489.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1475489.csv.gz"}},{"accession":"PRJNA299502","age_categories":{"adult":29,"elderly":5,"unknown":3},"countries":{"US":37},"first_public_year":"2015","gbp_per_sample_median":4.31,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":18,"type2_diabetes":19},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":37,"papers":[{"doi":"10.1016/j.cub.2015.10.060","pmcid":"PMC4703035","pmid":"26671671","title":"Gut Microbiome Diversity among Cheyenne and Arapaho Individuals from Western Oklahoma."},{"doi":"10.1371/journal.pone.0226930","pmcid":"PMC6961876","pmid":"31940321","title":"Biogeographic study of human gut-associated crAssphage suggests impacts from industrialization and recent expansion."},{"doi":"10.1186/s40168-021-01114-w","pmcid":"PMC8325300","pmid":"34330336","title":"HumGut: a comprehensive human gut prokaryotic genomes collection filtered by metagenome data."},{"doi":"10.1038/s41467-024-47272-x","pmcid":"PMC11009399","pmid":"38605009","title":"Plasmids in the human gut reveal neutral dispersal and recombination that is overpowered by inflammatory diseases."},{"doi":"10.1016/j.chom.2025.09.014","pmcid":"PMC13059687","pmid":"41118772","title":"Gut bacteria metabolize natural and synthetic steroid hormones via the reductive OsrABC pathway."}],"sample_intervention_arms":{},"sex":{"female":23,"male":14},"title":"Human Gut Microbiome Metagenome","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA299502","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA299502_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA299502.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA299502.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA299502.csv.gz"}},{"accession":"PRJNA1238196","age_categories":{"unknown":36},"countries":{},"first_public_year":"2025","gbp_per_sample_median":6.02,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":36},"intervention_design":"single_arm_before_after","intervention_detail":"Dapagliflozin (SGLT2i) 10mg/day, 8 weeks","interventions":["drug_therapy"],"n_samples":36,"papers":[{"doi":"10.3389/fphar.2025.1600464","pmcid":"PMC12095364","pmid":"40406484","title":"Reduced abundance of <i>Fusobacterium</i> signifies cardiovascular benefits of sodium glucose cotransporter 2 inhibitor in type 2 diabetes: a single arm clinical trial."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal samples from T2DM patients","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1238196","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1238196_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1238196.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1238196.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1238196.csv.gz"}},{"accession":"PRJNA809514","age_categories":{"adult":21,"elderly":15},"countries":{"CN":36},"first_public_year":"2022","gbp_per_sample_median":9.14,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":36},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":36,"papers":[{"doi":"10.3389/fmolb.2022.879294","pmcid":"PMC9240776","pmid":"35782875","title":"Polyethylene Glycol Loxenatide Injection (GLP-1) Protects Vascular Endothelial Cell Function in Middle-Aged and Elderly Patients With Type 2 Diabetes by Regulating Gut Microbiota."}],"sample_intervention_arms":{},"sex":{},"title":"Shorgun metagenomics of T2DM human gut microbes treated with GLP-1 drug","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA809514","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA809514_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA809514.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA809514.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA809514.csv.gz"}},{"accession":"PRJNA997572","age_categories":{"unknown":36},"countries":{"CN":36},"first_public_year":"2025","gbp_per_sample_median":6.43,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":36},"intervention_design":"single_arm_before_after","intervention_detail":"Metformin treatment in newly diagnosed T2DM patients","interventions":["drug_therapy"],"n_samples":36,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Research on the Mechanism of Metformin Improving Type 2 Diabetes","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA997572","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA997572_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA997572.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA997572.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA997572.csv.gz"}},{"accession":"PRJEB68381","age_categories":{"adult":18,"elderly":17},"countries":{"DE":35},"first_public_year":"2023","gbp_per_sample_median":0.08,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":9,"neurological_psychiatric":1,"other_cancer":1,"other_disease":17,"type2_diabetes":7},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":35,"papers":[{"doi":"10.1136/gutjnl-2023-330987","pmcid":"PMC10894816","pmid":"38129103","title":"Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis."}],"sample_intervention_arms":{},"sex":{"male":31},"title":"Pancreatitis - Microbiome As Predictor of Severity P-MAPS","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB68381","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB68381_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB68381.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB68381.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB68381.csv.gz"}},{"accession":"PRJNA1258603","age_categories":{"adult":34},"countries":{"IN":34},"first_public_year":"2025","gbp_per_sample_median":0.08,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":15,"type2_diabetes":10},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":34,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Human gut microbiome of Healthy and T2D individuals from Nagaland, India","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1258603","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1258603_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1258603.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1258603.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1258603.csv.gz"}},{"accession":"PRJNA638403","age_categories":{"adult":32,"elderly":2},"countries":{"CN":34},"first_public_year":"2020","gbp_per_sample_median":7.87,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":34,"papers":[{"doi":"10.1038/s41396-021-01016-7","pmcid":"PMC8528855","pmid":"34079079","title":"Compositional and genetic alterations in Graves' disease gut microbiome reveal specific diagnostic biomarkers."},{"doi":"10.1128/msystems.00828-23","pmcid":"PMC10734426","pmid":"37905808","title":"Cross-cohort single-nucleotide-variant profiling of gut microbiota suggests a novel gut-health assessment approach."},{"doi":"10.1186/s40168-025-02080-3","pmcid":"PMC11954268","pmid":"40158141","title":"Modeling microbiome-trait associations with taxonomy-adaptive neural networks."},{"doi":"10.1186/s12866-026-04902-2","pmcid":"PMC13067670","pmid":"41781883","title":"Metagenome-assembled genomes from the gut microbiome of spontaneous diabetic macaques provide insights into microbes associated with type 2 diabetes mellitus."}],"sample_intervention_arms":{},"sex":{"female":21,"male":13},"title":"Ecological and evolutionary alteration in the GD intestinal microbiome part05 Metagenome","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA638403","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA638403_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA638403.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA638403.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA638403.csv.gz"}},{"accession":"PRJEB51010","age_categories":{"adult":33},"countries":{},"first_public_year":"2022","gbp_per_sample_median":6.76,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":33},"intervention_design":"single_arm_before_after","intervention_detail":"Duodenal mucosal resurfacing ablation + GLP-1 receptor agonist in T2DM","interventions":["drug_therapy","surgery"],"n_samples":33,"papers":[{"doi":"10.3389/fcdhc.2022.856661","pmcid":"PMC10012157","pmid":"36992788","title":"A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study."}],"sample_intervention_arms":{},"sex":{},"title":"The effect of intestinal ablation on the microbiome","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB51010","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB51010_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB51010.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB51010.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB51010.csv.gz"}},{"accession":"PRJNA1430171","age_categories":{"adult":32},"countries":{"JP":32},"first_public_year":"2026","gbp_per_sample_median":0.66,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":32},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":32,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Metagenome sequencing for persons treated with antidiabetic drug","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1430171","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1430171_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1430171.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1430171.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1430171.csv.gz"}},{"accession":"PRJNA1046298","age_categories":{"adult":30},"countries":{"IN":30},"first_public_year":"2023","gbp_per_sample_median":0.12,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":30},"intervention_design":"randomized_controlled_trial","intervention_detail":"Microbiome-based personalized diet vs diabetic nutritional guidance, 3 months","interventions":["diet_intervention"],"n_samples":30,"papers":[{"doi":"10.7717/peerj.17583","pmcid":"PMC11214429","pmid":"38948211","title":"Microbiota based personalized nutrition improves hyperglycaemia and hypertension parameters and reduces inflammation: a prospective, open label, controlled, randomized, comparative, proof of concept s"}],"sample_intervention_arms":{},"sex":{},"title":"Microbiota based personalized nutrition improves hyperglycaemia and hypertension parameters and reduces inflammation: A prospective, open label, controlled, randomized, comparative, proof of concept study.","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1046298","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1046298_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1046298.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1046298.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1046298.csv.gz"}},{"accession":"PRJNA1365953","age_categories":{"adult":30},"countries":{"CN":30},"first_public_year":"2025","gbp_per_sample_median":6.53,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":30,"papers":[{"doi":"10.1038/s41598-026-51805-3","pmcid":"PMC13358107","pmid":"42120930","title":"The gut microbiota and metabolomics in the pathogenesis of type 2 diabetes mellitus combined with coronary atherosclerotic heart disease."}],"sample_intervention_arms":{},"sex":{},"title":"Macrogenetic data on diabetes mellitus and diabetes mellitus-combined coronary heart disease","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1365953","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1365953_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1365953.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1365953.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1365953.csv.gz"}},{"accession":"PRJNA821541","age_categories":{"adolescent":21,"child":9},"countries":{"MX":30},"first_public_year":"2023","gbp_per_sample_median":6.1,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":10,"type2_diabetes":10},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":30,"papers":[{"doi":"10.3389/fped.2023.1193832","pmcid":"PMC10277889","pmid":"37342535","title":"Gut microbial composition and functionality of school-age Mexican population with metabolic syndrome and type-2 diabetes mellitus using shotgun metagenomic sequencing."},{"doi":"10.1038/s41598-025-04343-3","pmcid":"PMC12134222","pmid":"40461716","title":"Lipidomic signatures linked to gut microbiota alterations in children and adolescents with type 2 diabetes mellitus and metabolic syndrome."}],"sample_intervention_arms":{},"sex":{"female":13,"male":17},"title":"Gut microbiome studies in school-age Mexican population","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA821541","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA821541_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA821541.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA821541.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA821541.csv.gz"}},{"accession":"PRJNA855128","age_categories":{"adult":26},"countries":{"CN":26},"first_public_year":"2022","gbp_per_sample_median":10.53,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":26,"papers":[{"doi":"10.3389/fimmu.2022.943325","pmcid":"PMC9434375","pmid":"36059453","title":"Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetes."}],"sample_intervention_arms":{},"sex":{},"title":"Stool Metagenome Raw sequence reads","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA855128","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA855128_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA855128.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA855128.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA855128.csv.gz"}},{"accession":"PRJNA910923","age_categories":{"adult":26},"countries":{"CN":26},"first_public_year":"2023","gbp_per_sample_median":10.72,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":26},"intervention_design":"single_arm_before_after","intervention_detail":"Metformin treatment 3-6 months in T2D patients","interventions":["drug_therapy"],"n_samples":26,"papers":[{"doi":"10.1038/s41522-023-00419-y","pmcid":"PMC10366088","pmid":"37488134","title":"Bacteroides ovatus accelerates metformin-induced vitamin B12 deficiency in type 2 diabetes patients by accumulating cobalamin."}],"sample_intervention_arms":{"drug_therapy":26},"sex":{"female":10,"male":16},"title":"Gut microbiota accelerate metformin-induced vitamin B12 deficiency","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA910923","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA910923_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA910923.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA910923.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA910923.csv.gz"}},{"accession":"PRJNA386502","age_categories":{"unknown":25},"countries":{"US":25},"first_public_year":"2017","gbp_per_sample_median":8.35,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":25},"intervention_design":"single_arm_before_after","intervention_detail":"Faecal microbiota transplantation in pre-diabetic patients","interventions":["fmt"],"n_samples":25,"papers":[],"sample_intervention_arms":{"fmt":12,"no_intervention":12},"sex":{},"title":"Pre-Diabetic FMT","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA386502","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA386502_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA386502.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA386502.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA386502.csv.gz"}},{"accession":"PRJEB54728","age_categories":{"adult":24},"countries":{"CN":24},"first_public_year":"2022","gbp_per_sample_median":3.45,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":12,"type2_diabetes":12},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":24,"papers":[{"doi":"10.1186/s12866-023-02852-7","pmcid":"PMC10105465","pmid":"37060052","title":"Differences in gut microbiota and its metabolic function among different fasting plasma glucose groups in Mongolian population of China."},{"doi":"10.21203/rs.3.rs-1786308/v1","pmcid":null,"pmid":null,"title":"Differences in gut microbiota and its metabolic function among different fasting plasma glucose groups in Mongolian population of China"}],"sample_intervention_arms":{},"sex":{},"title":"Differences in gut microbiota and its metabolic function among different fasting plasma glucose groups in Mongolian population of China","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB54728","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB54728_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB54728.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB54728.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB54728.csv.gz"}},{"accession":"PRJNA1052403","age_categories":{"adult":23},"countries":{"CN":23},"first_public_year":"2024","gbp_per_sample_median":3.69,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":23,"papers":[{"doi":"10.1038/s41467-024-51864-y","pmcid":"PMC11402979","pmid":"39278950","title":"An expanded database and analytical toolkit for identifying bacterial virulence factors and their associations with chronic diseases."}],"sample_intervention_arms":{},"sex":{},"title":"Pacbio SMRT sequencing of gut microbime of T2D patients","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1052403","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1052403_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1052403.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1052403.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1052403.csv.gz"}},{"accession":"PRJNA1241990","age_categories":{"unknown":23},"countries":{"KR":23},"first_public_year":"2025","gbp_per_sample_median":4.82,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":23},"intervention_design":"single_arm_before_after","intervention_detail":"Roux-en-Y gastric reconstruction after gastrectomy, T2DM patients","interventions":["surgery"],"n_samples":23,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"human fecal microbiome after Roux-en-Y reconstruction","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1241990","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1241990_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1241990.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1241990.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1241990.csv.gz"}},{"accession":"PRJDB5860","age_categories":{"adult":15,"elderly":3},"countries":{"MN":18},"first_public_year":"2025","gbp_per_sample_median":5.61,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":9,"type2_diabetes":9},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":18,"papers":[{"doi":"10.3389/fmicb.2018.01345","pmcid":"PMC6024022","pmid":"29988433","title":"Urban Diets Linked to Gut Microbiome and Metabolome Alterations in Children: A Comparative Cross-Sectional Study in Thailand."},{"doi":"10.1007/s13205-020-02265-7","pmcid":"PMC7261292","pmid":"32537376","title":"Age-related changes in the gut microbiota and the core gut microbiome of healthy Thai humans."},{"doi":"10.1093/gigascience/giac077","pmcid":"PMC9366992","pmid":"35950838","title":"A machine learning framework for discovery and enrichment of metagenomics metadata from open access publications."},{"doi":"10.3389/fmicb.2024.1355396","pmcid":"PMC11231203","pmid":"38983625","title":"Gut microbiome signatures associated with type 2 diabetes in obesity in Mongolia."}],"sample_intervention_arms":{},"sex":{"female":11,"male":7},"title":"Asian Microbiome Project","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB5860","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB5860_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB5860.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB5860.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB5860.csv.gz"}},{"accession":"PRJNA275687","age_categories":{"adult":16},"countries":{"MY":16},"first_public_year":"2016","gbp_per_sample_median":0.18,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":6,"obesity":5,"type2_diabetes":5},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":16,"papers":[{"doi":"10.6026/97320630014560","pmcid":"PMC6563668","pmid":"31223215","title":"Enterotype Variations of the Healthy Human Gut Microbiome in Different Geographical Regions."}],"sample_intervention_arms":{},"sex":{},"title":"HUMAN GUTMICROBIOTA Metagenome","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA275687","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA275687_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA275687.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA275687.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA275687.csv.gz"}},{"accession":"PRJNA313232","age_categories":{"unknown":10},"countries":{"CN":7,"DK":2,"ES":1},"first_public_year":"2016","gbp_per_sample_median":0.08,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Acarbose treatment in mice (diabetes drug, starch digestion inhibitor)","interventions":["drug_therapy"],"n_samples":10,"papers":[{"doi":"10.1186/s40168-016-0181-2","pmcid":"PMC4936053","pmid":"27388460","title":"Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals."},{"doi":"10.1128/msphere.00851-21","pmcid":"PMC8636109","pmid":"34851167","title":"Muribaculaceae Genomes Assembled from Metagenomes Suggest Genetic Drivers of Differential Response to Acarbose Treatment in Mice."}],"sample_intervention_arms":{},"sex":{},"title":"Bacteroidales group S24-7 population genome recovery","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA313232","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA313232_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA313232.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA313232.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA313232.csv.gz"}},{"accession":"PRJNA1087526","age_categories":{"adult":7},"countries":{"CN":7},"first_public_year":"2024","gbp_per_sample_median":6.49,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":7},"intervention_design":"unknown","intervention_detail":"Human stool metagenomics observational; L. johnsonii probiotic given to diabetic mice only","interventions":["probiotic"],"n_samples":7,"papers":[{"doi":"10.1038/s41598-025-94359-6","pmcid":"PMC13201571","pmid":"41904207","title":"Impact of Lactobacillus johnsonii on glycemic control and lipid metabolism in type 2 diabetes with circadian disruption."}],"sample_intervention_arms":{},"sex":{"male":7},"title":"The effect of gut microbiota on the prognosis of type 2 diabetes mellitus complicated with circadian clock disorder","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1087526","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1087526_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1087526.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1087526.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1087526.csv.gz"}}],"release":"R2026.25"}